Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Thrombosis and Haemostasis|March 8, 2003
Prothrombin G20210A mutation and oral contraceptive use increase upper-extremity deep vein thrombotic riskAmparo Vayá, Yolanda Mira, Jose Mateo, et al.
Blood|May 16, 2002
Platelet-erythrocyte interactions enhance alpha(IIb)beta(3) integrin receptor activation and P-selectin expression during platelet recruitment: down-regulation by aspirin ex vivoJuana Vallés, M Teresa Santos, Justo Aznar, et al.
The American Journal of Cardiology|January 2, 2007
Partial inhibition of platelet thromboxane A2 synthesis by aspirin is associated with myonecrosis in patients with ST-segment elevation myocardial infarctionJuana Valles, M Teresa Santos, M Paz Fuset, et al.
Thrombosis and Haemostasis|April 8, 2006
Thrombophilic risk factors and homocysteine levels in Behçet's disease in eastern Spain and their association with thrombotic eventsJosé Ma Ricart, Amparo Vayá, José Todolí, et al.
Circulation|September 1, 2004
Homozygous deficiency of heparin cofactor II: relevance of P17 glutamate residue in serpins, relationship with conformational diseases, and role in thrombosisJavier Corral, Justo Aznar, Rocio Gonzalez-Conejero, et al.
Clinical Chemistry|July 27, 2002
The proportion of prostate-specific antigen (PSA) complexed to alpha(1)-antichymotrypsin improves the discrimination between prostate cancer and benign prostatic hyperplasia in men with a total PSA of 10 to 30 microg/LManuel Martínez, Francisco España, Montserrat Royo, et al.
European Urology|May 28, 2003
The role of the complexed-to-total prostate-specific antigen ratio in predicting the final pathological stage of clinically localized prostate cancerManuel Martínez, Silvia Navarro, Pilar Medina, et al.
British Journal of Haematology|August 4, 2004
Activated protein C levels in Behçet's disease and risk of venous thrombosisSilvia Navarro, José María Ricart, Pilar Medina, et al.
The Journal of Laboratory and Clinical Medicine|May 16, 2006
Aspirin therapy for inhibition of platelet reactivity in the presence of erythrocytes in patients with vascular diseaseM Teresa Santos, Juana Vallés, Justo Aznar, et al.
Thrombosis and Haemostasis|April 30, 2004
Contribution of polymorphisms in the endothelial protein C receptor gene to soluble endothelial protein C receptor and circulating activated protein C levels, and thrombotic riskPilar Medina, Silvia Navarro, Amparo Estellés, et al.
Pageof 7